Ariad Screams on Upgrade (ARIA)
Ariad Pharmaceuticals Inc. (NASDAQ: ARIA) is one of the top gainers in the pre-market trading session. Shares were raised to Overweight from Neutral at JP Morgan based on Phase I leukemia data due next month and on additional test results due in 2010. At 8:11 AM EST we have shares trading up 10.6% at $2.40 [...]
VS Investor RSS Feed
